The use of radiation therapy in the geriatric population.
The foregoing, it is hoped, has provided at least a taste of the past, present, and future in the use of RT for the elderly population. Based on many ongoing studies, it becomes clear that the radiation oncology world has come to recognize the geriatric population’s ability to tolerate, and perhaps even thrive from, a course of RT, when it is offered appropriately. In the final analysis, it has become clear that no simple age cutoff can substitute for clinical acumen and a thorough assessment of patients’ general health before the best treatment regimen can be chosen. One need only follow the trend both in American and in European trials (the RTOG and the EORTC) to appreciate the acceptance that has taken hold that there need not be an age cutoff so much as a set of clinical criteria, including performance status and other assessments of function and comorbidity, prior to patient enrollment in anational trial. With such an outlook, we eagerly anticipate the results from these trials and look forward to implementing them in our treatment of young and old patients alike.
Department of Radiation Oncology, Holy Name Medical Center, Teaneck, NJ 07666, USA. bdrosenbluth@yahoo.com
Benjamin
B
Rosenbluth
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005853:Geriatrics; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000532:radiotherapy*; D018787:Radiation Oncology / Q000639:trends; D011878:Radiotherapy / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome